Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Previderm Nasal is a cosmetic topical bioadhesive gel developed by Ojer Pharma for the protection and repair of the external nasal area. It is formulated with 2% *Centella asiatica* and 2% Allantoin. The product is designed to soothe, moisturize, and protect skin that has been irritated by environmental factors such as cold, wind, or frequent tissue use during respiratory infections. It utilizes a proprietary bioadhesive technology that creates a protective film over the skin, facilitating the sustained release of its active ingredients to promote skin recovery. Previderm Nasal is marketed as a cosmetic product in several European countries, including Spain, Portugal, and Italy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Previderm Nasal.